Pathological response in a triple-negative breast cancer cohort treated with neoadjuvant carboplatin and docetaxel according to Lehmann’s refined classification

PURPOSE: Triple-negative breast cancer (TNBC) requires the identification of reliable predictors of response to neoadjuvant chemotherapy (NACT). For this purpose, we aimed to evaluate the performance of the TNBCtype-4 classifier in a cohort of TNBC patients treated with neoadjuvant carboplatin and d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Echavarria, Isabel, López-Tarruella, Sara, Picornell, Antoni, García-Saenz, Jose Ángel, Yolanda Jerez, Y, Hoadley, Katherine, Gómez, Henry L, Moreno, Fernando, Del Monte-Millan, María, Márquez-Rodas, Iván, Alvarez, Enrique, Ramos-Medina, Rocío, Gayarre, Javier, Massarrah, Tatiana, Ocaña, Inmaculada, Cebollero, María, Fuentes, Hugo, Barnadas, Agusti, Ballesteros, Ana Isabel, Bohn, Uriel, Perou, Charles M, Martin, Miguel
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5899625/
https://ncbi.nlm.nih.gov/pubmed/29378733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-17-1912
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados